The American Diabetes Association has endorsed the measurement of the gycosylated hemoglobin (HbA1c) level as an accurate diagnostic test for diabetes. An HbA1c level of < 7% indicates good blood glucose level control. Hypoglycemia is defined as a confirmed blood glucose value of ≤ 70 mg/dL. The HbA1c levels in this study were analyzed twice during the study, once at baseline and once at 12 weeks after the FGMS testing was initiated, by COBAS INTEGRA 400 plus/800 analyzers (Roche Diagnostics, Indianapolis, IN, USA) at the central laboratory of PSMMC.
At baseline, clinical data for the preceding 4 weeks, including frequency of conventional self-monitoring of blood glucose (SMBG) by fingerprick and frequency of hypoglycemia, were collected using the FreeStyle Optium Neo® blood glucose meter (Abbott Laboratories) equipped with the FreeStyle Auto-Assist Neo®software prior to the commencement study, At 12 weeks after baseline, the flash data were collected from the FGMS sensors and computed to generate the respective AGPs so as to determine the total number of scans conducted and the frequency of hypoglycemia during the study period. Study participants were instructed to take capillary measurements if they experienced impending or possible hypoglycemic events, glycemic variability, or inconsistent symptoms using the in-built blood glucose meter reader.
At baseline, clinical data for the preceding 4 weeks, including frequency of conventional self-monitoring of blood glucose (SMBG) by fingerprick and frequency of hypoglycemia, were collected using the FreeStyle Optium Neo® blood glucose meter (Abbott Laboratories) equipped with the FreeStyle Auto-Assist Neo®software prior to the commencement study, At 12 weeks after baseline, the flash data were collected from the FGMS sensors and computed to generate the respective AGPs so as to determine the total number of scans conducted and the frequency of hypoglycemia during the study period. Study participants were instructed to take capillary measurements if they experienced impending or possible hypoglycemic events, glycemic variability, or inconsistent symptoms using the in-built blood glucose meter reader.